XML 28 R27.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Quarterly Data (Unaudited)
12 Months Ended
Dec. 31, 2010
Quarterly Data (Unaudited)  
Quarterly Data (Unaudited)

NOTE 19.  Quarterly Data (Unaudited)

 

(Millions, except per-share amounts)
2010

 

First
Quarter

 

Second
Quarter

 

Third
Quarter

 

Fourth
Quarter

 

Year
2010

 

Net sales

 

$

6,348

 

$

6,731

 

$

6,874

 

$

6,709

 

$

26,662

 

Cost of sales

 

3,238

 

3,435

 

3,583

 

3,575

 

13,831

 

Net income attributable to 3M

 

930

 

1,121

 

1,106

 

928

 

4,085

 

Earnings per share attributable to 3M common shareholders — basic

 

1.31

 

1.57

 

1.55

 

1.30

 

5.72

 

Earnings per share attributable to 3M common shareholders — diluted

 

1.29

 

1.54

 

1.53

 

1.28

 

5.63

 

 

(Millions, except per-share amounts)
2009

 

First
Quarter

 

Second
Quarter

 

Third
Quarter

 

Fourth
Quarter

 

Year
2009

 

Net sales

 

$

5,089

 

$

5,719

 

$

6,193

 

$

6,122

 

$

23,123

 

Cost of sales

 

2,772

 

2,977

 

3,171

 

3,189

 

12,109

 

Net income attributable to 3M

 

518

 

783

 

957

 

935

 

3,193

 

Earnings per share attributable to 3M common shareholders — basic

 

0.75

 

1.12

 

1.36

 

1.32

 

4.56

 

Earnings per share attributable to 3M common shareholders — diluted

 

0.74

 

1.12

 

1.35

 

1.30

 

4.52

 

 

Gross profit is calculated as net sales minus cost of sales. In the first quarter of 2010, a charge resulting from the March 2010 enactment of the Patient Protection and Affordable Care Act, including modifications made in the Health Care and Education Reconciliation Act of 2010, decreased net income attributable to 3M by $84 million ($0.12 per diluted share impact on year 2010). In 2009, restructuring charges, partially offset by a gain on sale of real estate, decreased net income attributable to 3M by $119 million, or $0.17 per diluted share, with $45 million ($0.07 per diluted share) in the first quarter, $60 million ($0.08 per diluted share) in the second quarter and $14 million ($0.02 per diluted share) in the third quarter.